tiprankstipranks
Trending News
More News >
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Income Statement

Compare
62 Followers

Impact BioMedical, Inc. Income Statement

Last quarter (Q3 2023), Impact BioMedical, Inc.'s total revenue was C$428.33K, an increase of 16.04% from the same quarter last year. In Q3, Impact BioMedical, Inc.'s net income was C$-486.60K. See Impact BioMedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 22Sep 21Mar 20Mar 19
Total Revenue
C$ 1.07MC$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 1.07MC$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 5.82MC$ 3.86MC$ 59.24KC$ 68.85K
Depreciation and Amortization
C$ 266.40KC$ 69.86KC$ 255.00C$ 171.86K
EBITDA
C$ -4.61MC$ -3.76MC$ 638.00C$ -33.86K
Operating Income
C$ 497.15KC$ -3.83MC$ 383.00C$ -33.86K
Other Income/Expenses
C$ -5.68MC$ -19.15KC$ -59.63KC$ -34.99K
Pretax Income
C$ -10.50MC$ -3.87MC$ -118.31KC$ -98.11K
Net Income
C$ -10.50MC$ -3.87MC$ -118.31KC$ -98.11K
Per Share Metrics
Basic EPS
C$ -0.06C$ -0.03C$ -0.01C$ -0.01
Diluted EPS
C$ -0.06C$ -0.03C$ -0.01C$ -0.01
Weighted Average Shares Outstanding
185.64M 125.19M 11.83M 9.81M
Weighted Average Shares Outstanding (Diluted)
185.64M 125.19M 11.83M 9.81M
Currency in CAD

Impact BioMedical, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis